Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Testicular Hydrocele

ClinicalTrials.gov lists 23 trials for Testicular Hydrocele or a narrower condition beneath it. Hillel Yaffe Medical Center has the most among industry and government lead sponsors, with 1.

MeSH D006848 Urogenital Diseases C12 C19
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 2 Phase 2 2 Phase 3 Phase 3 1 Not applicable Not applicable 11 Observational Observational 9 Phase 2 Phase 2 2 Phase 3 Phase 3 1 Not applicable Not applicable 11 Observational Observational 9

Trials per phase

23 of the 23 trials are tagged with Testicular Hydrocele itself; the rest are tagged with a narrower condition beneath it.

Get the Testicular Hydrocele report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Testicular Hydrocele trials start? (12)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.

Trials over time, by phase

  • Phase 2
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 4

2002: 3 trials (Observational 3) 2008: 1 trials (Phase 2 1) 2009: 1 trials (Phase 2 1) 2012: 1 trials (Not applicable 1) 2013: 3 trials (Observational 2, Not applicable 1) 2014: 1 trials (Not applicable 1) 2015: 2 trials (Observational 1, Not applicable 1) 2017: 1 trials (Not applicable 1) 2018: 4 trials (Observational 1, Not applicable 3) 2020: 1 trials (Observational 1) 2021: 2 trials (Not applicable 1, Phase 3 1) 2022: 2 trials (Observational 1, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2022 2
2021 2
2020 1
2018 4
2017 1
2015 2
2014 1
2013 3
2012 1
2009 1

No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Testicular Hydrocele trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 2 2
Phase 3 1
Not applicable 11
Observational 9

How many Testicular Hydrocele trials are recruiting? (5)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Active, not recruiting 2
Completed 13
Terminated 1
Unknown status 6

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Testicular Hydrocele trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
Hillel Yaffe Medical Center 1

Which drugs are being tested for Testicular Hydrocele? (1)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
+/- Bupivacaine HCl 1

Interventions as named in the registry (10)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Ibuprofen 2% 1
Exparel 133 miligrams per 10 milliliter injection 1
PO Morphine 1
Injection of 0,2 ml/kg of 0,2% levobupivacaine for small volume group 1
Sclerotherapy 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which publications cover Testicular Hydrocele? (25)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages